Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Cyclosporins|DRUG: nab-paclitaxel
Sponsor: Northwestern University
Collaborators: Avon Foundation